D
Tyra Biosciences, Inc. TYRA
$14.50 -$0.34-2.29% NASDAQ
Recommendation
Prev Close
$14.84
Volume
161,375
Avg Vol (90D)
246,191
Market Cap
$790.93M
Dividend & Yield
--
52-Week Range
$6.42 - $29.60
P/E (TTM)
--
EPS (TTM)
-$1.79
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Tyra Biosciences (TYRA, $14.84) Aroon Indicator entered an Uptrend on October 16, 2025.
10/17/2025 - Tickeron - Stocks
Tyra Biosciences (TYRA, $14.84) RSI Indicator left the overbought zone on October 16, 2025
10/17/2025 - Tickeron - Stocks
Tyra Biosciences (NASDAQ:TYRA) Trading Up 7.2% - Time to Buy?
10/16/2025 - MarketBeat
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Average Recommendation of "Moderate Buy" from Analysts
10/16/2025 - Ticker Report
Tyra Biosciences (TYRA, $15.3) Aroon Indicator entered an Uptrend on October 15, 2025.
10/16/2025 - Tickeron - Stocks
Tyra Biosciences (TYRA, $15.3) entered Uptrend as Momentum indicator ascends above 0 level on Oct 15, 2025
10/16/2025 - Tickeron - Stocks
Tyra Biosciences (TYRA, $13.92) Aroon Indicator entered an Uptrend on October 14, 2025.
10/15/2025 - Tickeron - Stocks
Tyra Biosciences (TYRA, $13.92) entered Downtrend as Momentum indicator drops below 0 level on Oct 14, 2025
10/15/2025 - Tickeron - Stocks
Analysts Expect AVSU Will Reach $82
10/14/2025 - ETF Channel
Tyra Biosciences (TYRA, $14.36) Moving Average Convergence Divergence (MACD) Histogram turned positive on October 13, 2025
10/14/2025 - Tickeron - Technical Analysis
Tyra Biosciences (TYRA, $14.36) Aroon Indicator entered an Uptrend on October 13, 2025.
10/14/2025 - Tickeron - Technical Analysis
Tyra Biosciences (TYRA, $13.52) Aroon Indicator entered an Uptrend on October 10, 2025.
10/11/2025 - Tickeron - Stocks
Tyra Biosciences (TYRA, $13.52) Moving Average Convergence Divergence (MACD) Histogram turned negative on October 10, 2025
10/11/2025 - Tickeron - Stocks
Tyra Biosciences (TYRA, $13.82) Aroon Indicator entered an Uptrend on October 09, 2025.
10/10/2025 - Tickeron - Stocks
Tyra Biosciences' (TYRA) Sell (D-) Rating Reiterated at Weiss Ratings
10/10/2025 - MarketBeat
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Average Rating of "Moderate Buy" from Brokerages
10/9/2025 - MarketBeat
Tyra Biosciences (TYRA, $13.42) RSI Indicator left the overbought zone on October 01, 2025
10/2/2025 - Tickeron - Stocks
We Think Tyra Biosciences (NASDAQ:TYRA) Can Afford To Drive Business Growth
10/1/2025 - Simply Wall St
Tyra Biosciences (TYRA, $13.3) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 29, 2025
9/30/2025 - Tickeron - Stocks
Tyra Biosciences (TYRA, $13.3) Aroon Indicator entered an Uptrend on September 29, 2025.
9/30/2025 - Tickeron - Stocks
Tyra Biosciences, Inc. $TYRA Shares Sold by Canaan Partners XI LLC
9/30/2025 - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Cut to "Sell" at Wall Street Zen
9/29/2025 - Ticker Report
Tyra Biosciences (TYRA, $12.97) Aroon Indicator entered an Uptrend on September 26, 2025.
9/27/2025 - Tickeron - Stocks
Tyra Biosciences (NASDAQ:TYRA) Downgraded to Sell Rating by Wall Street Zen
9/27/2025 - MarketBeat
Tyra Biosciences (TYRA, $12.89) entered Uptrend as Momentum indicator ascends above 0 level on Sep 22, 2025
9/23/2025 - Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$121.10M
EBIT (TTM)
-$121.65M
Net Income (TTM)
-$105.83M
Balance Sheet
Total Assets (Q)
$321.50M
Total Debt (Q)
$6.02M
Total Liabilities (Q)
$19.35M
Book Value Per Share (Q)
$5.68
Cash Flow
Cash from Operations (TTM)
-$86.63M
Cash from Investing (TTM)
$81.41M
Cash from Financing (TTM)
$4.22M
Net Change in Cash (TTM)
-$1.00M
Filings
Filing Date
Thursday, August 14, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
1.59
7-Day Total Return
6.38%
30-Day Total Return
14.62%
60-Day Total Return
34.51%
90-Day Total Return
35.39%
Year to Date Total Return
0.49%
1-Year Total Return
-44.19%
2-Year Total Return
-1.43%
3-Year Total Return
124.46%
5-Year Total Return
--
52-week Low
Apr 09, 2025 - $6.42
52-week High
Oct 24, 2024 - $29.60
Valuation
Market Cap
$790.93M - Small Cap
Enterprise Value
$500.68M
Price/Sales (TTM)
--
Price/Book (Q)
2.61
Dividends and Shares
Shares Outstanding
59.55
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
tyra.bio
Phone Number
619 728 4760
Address
2656 State Street
Carlsbad, CA 92008
Country
United States
Year Founded
2018
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a... more
NASDAQ 10/17/2025 4:00PM Eastern Quotes delayed